The accumulation of iron, such as ferrous Fe2+, in the Alzheimer's disease (AD) brain may contribute to neurodegeneration by driving oxidative stress. While elevated iron in AD has been shown, the oxidation state of iron and its regional distribution in AD, particularly in the hippocampus, is unclear.
Objective
To characterize the oxidation state and spatial distribution of iron in the hippocampus of AD and control brains, and to assess the effect of tissue thawing on ferrous iron measurements.
Methods
We utilized X-ray fluorescence imaging and X-ray absorption near edge structure spectroscopy to localize and analyze iron deposition in fresh-frozen human hippocampal specimens stratified by AD disease stage. To assess the effect of thawing on iron oxidation, we used a cryo-chamber to keep three specimens frozen while their respective deposits were being scanned. These specimens were then allowed to thaw and their same deposits were rescanned for comparison.
Results
Compared to control brains, AD specimens exhibited elevated levels of ferrous iron (Fe2+) in the cornu ammonis 1 (CA1)-subiculum subfields—regions known to degenerate early in AD. We also measured a decrease in Fe2+ levels in AD and control specimens scanned after being thawed.
Conclusions
Our findings support the association between elevated Fe2+ and AD, consistent with existing hypotheses linking redox-active iron to oxidative stress and neuroinflammation. The observed reduction in Fe2+ levels following thawing suggests that studies using thawed brain samples may underestimate Fe2+ levels.
RajanKBWeuveJBarnesLL, et al.Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060). Alzheimers Dement2021; 17: 1966–1975.
2.
JackCRBennettDABlennowK, et al.NIA-AA Research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement2018; 14: 535–562.
3.
JackCRJrAndrewsJSBeachTG, et al.Revised criteria for diagnosis and staging of Alzheimer’s disease: Alzheimer’s Association Workgroup. Alzheimers Dement2024; 20: 5143–5169.
4.
KnopmanDSJonesDTGreiciusMD. Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimers Dement2021; 17: 696–701.
5.
KametaniFHasegawaM. Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer’s disease. Front Neurosci2018; 12: 25.
6.
van der KantRGoldsteinLSBOssenkoppeleR. Amyloid-β-independent regulators of tau pathology in Alzheimer disease. Nat Rev Neurosci2020; 21: 21–35.
7.
MorimotoKHorioJSatohH, et al.Expression profiles of cytokines in the brains of Alzheimer’s disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology. J Alzheimers Dis2011; 25: 59–76.
8.
ParachikovaAAgadjanyanMGCribbsDH, et al.Inflammatory changes parallel the early stages of Alzheimer disease. Neurobiol Aging2007; 28: 1821–1833.
9.
GuerreiroRWojtasABrasJ, et al.TREM2 Variants in Alzheimer’s disease. N Engl J Med2013; 368: 117–127.
10.
JonssonTStefanssonHSteinbergS, et al.Variant of TREM2 associated with the risk of Alzheimer’s disease. N Engl J Med2013; 368: 107–116.
11.
BradshawEMChibnikLBKeenanBT, et al.CD33 Alzheimer’s disease locus: altered monocyte function and amyloid biology. Nat Neurosci2013; 16: 848–850.
12.
GriciucASerrano-PozoAParradoAR, et al.Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron2013; 78: 631–643.
13.
SimsRvan der LeeSJNajAC, et al.Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease. Nat Genet2017; 49: 1373–1384.
14.
WeldonDTRogersSDGhilardiJR, et al.Fibrillar β-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci1998; 18: 2161–2173.
15.
GuelaCWuC-KSaroffD, et al.Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat Med1998; 4: 827–831.
16.
YangTLiSXuH, et al.Large soluble oligomers of amyloid β-protein from Alzheimer brain are far less neuroactive than the smaller oligomers to which they dissociate. J Neurosci2017; 37: 152–163.
17.
RodriguezGATaiLMLaDuMJ, et al.Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition. J Neuroinflammation2014; 11: 111.
18.
AsaiHIkezuSTsunodaS, et al.Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci2015; 18: 1584–1593.
19.
UrrutiaPJ. Bórquez DA and Núñez MT. Inflaming the brain with iron. Antioxidants2021; 10: 61.
20.
ZhangWYanZGaoJ, et al.Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration. Mol Neurobiol2014; 49: 1153–1165.
21.
Grundke-IqbalIFlemingJTungYC, et al.Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (Berl)1990; 81: 105–110.
22.
ConnorJRMenziesSLSt. MartinSM, et al.A histochemical study of iron, transferrin, and ferritin in Alzheimer’s diseased brains. J Neurosci Res1992; 31: 75–83.
23.
MeadowcroftMDConnorJRYangQX. Cortical iron regulation and inflammatory response in Alzheimer’s disease and APPSWE/PS1ΔE9 mice: a histological perspective. Front Neurosci2015; 9: 255.
24.
ZeinehMMChenYKitzlerHH, et al.Activated iron-containing microglia in the human hippocampus identified by magnetic resonance imaging in Alzheimer disease. Neurobiol Aging2015; 36: 2483–2500.
25.
RathoreKIRedensekADavidS. Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-α and TGF-β1. Glia2012; 60: 738–750.
26.
UrrutiaPAguirrePEsparzaA, et al.Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem2013; 126: 541–549.
27.
SmithMAHarrisPLSayreLM, et al.Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci U S A1997; 94: 9866–9868.
28.
QuintanaCCowleyJMMarhicC. Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin. J Struct Biol2004; 147: 166–178.
29.
PankhurstQHautotDKhanN, et al.Increased levels of magnetic iron compounds in Alzheimer’s disease. J Alzheimers Dis2008; 13: 49–52.
30.
EverettJBrooksJLermyteF, et al.Iron stored in ferritin is chemically reduced in the presence of aggregating Aβ(1-42). Sci Rep2020; 10: 10332.
31.
EverettJCollingwoodJFTjendana-TjhinV, et al.Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer’s disease subjects. Nanoscale2018; 10: 11782–11796.
32.
EverettJCéspedesEShelfordLR, et al.Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer’s disease peptide β-amyloid. Inorg Chem2014; 53: 2803–2809.
33.
EverettJCéspedesEShelfordLR, et al.Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer’s disease peptide β-amyloid (1–42). J R Soc Interface2014; 11: 20140165.
34.
BalejcikovaLSiposovaKKopcanskyP, et al.Fe(II) formation after interaction of the amyloid β-peptide with iron-storage protein ferritin. J Biol Phys2018; 44: 237–243.
35.
TranDDiGiacomoPBornDE, et al.Iron and Alzheimer’s disease: from pathology to imaging. Front Hum Neurosci2022; 16: 838692.
36.
CollingwoodJFChongRKKKasamaT, et al.Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer’s plaque core material. J Alzheimers Dis2008; 14: 235–245.
37.
ZengYDiGiacomoPSMadsenSJ, et al.Exploring valence states of abnormal mineral deposits in biological tissues using correlative microscopy and spectroscopy techniques: a case study on ferritin and iron deposits from Alzheimer’s disease patients. Ultramicroscopy2021; 231: 113254.
38.
MadsenSJDiGiacomoPSZengY, et al.Correlative microscopy to localize and characterize iron deposition in Alzheimer’s disease. J Alzheimers Dis Rep2020; 4: 525–536.
39.
GarvieLAJZegaTJRezP, et al.Nanometer-scale measurements of Fe3+/ΣFe by electron energy-loss spectroscopy: a cautionary note. Am Mineral2004; 89: 1610–1616.
40.
PushieMJPickeringIJKorbasM, et al.Elemental and chemically specific X-ray fluorescence imaging of biological systems. Chem Rev2014; 114: 8499–8541.
41.
FahrniCJ. Biological applications of X-ray fluorescence microscopy: exploring the subcellular topography and speciation of transition metals. Curr Opin Chem Biol2007; 11: 121–127.
42.
McRaeRBagchiPSumalekshmyS, et al.In situ imaging of metals in cells and tissues. Chem Rev2009; 109: 4780–4827.
43.
QinZCarusoJALaiB, et al.Trace metal imaging with high spatial resolution: applications in biomedicine. Metallomics2011; 3: 28–37.
44.
CotteMWelcommeESoléVA, et al.Synchrotron-based X-ray spectromicroscopy used for the study of an atypical micrometric pigment in 16th century paintings. Anal Chem2007; 79: 6988–6994.
45.
SomogyiADrakopoulosMVinczeL, et al.ID18F: A new micro-x-ray fluorescence end-station at the European Synchrotron Radiation Facility (ESRF): preliminary results. X-ray spectrom2001; 30: 242–252.
46.
CollingwoodJFMikhaylovaADavidsonM, et al.In situ characterization and mapping of iron compounds in Alzheimer’s disease tissue. J Alzheimers Dis2005; 7: 267–272.
47.
FinneganMEVisanjiNPRomero-CanelonI, et al.Synchrotron XRF imaging of Alzheimer’s disease basal ganglia reveals linear dependence of high-field magnetic resonance microscopy on tissue iron concentration. J Neurosci Methods2019; 319: 28–39.
48.
AntharamVCollingwoodJFBullivantJ-P, et al.High field magnetic resonance microscopy of the human hippocampus in Alzheimer’s disease: quantitative imaging and correlation with iron. NeuroImage2012; 59: 1249–1260.
49.
BajtSSuttonSRDelaneyJS. X-ray microprobe analysis of iron oxidation states in silicates and oxides using X-ray absorption near edge structure (XANES). Geochim Cosmochim Acta1994; 58: 5209–5214.
50.
DelaneyJSDyarMDSuttonSR, et al.Redox ratios with relevant resolution: solving an old problem by using the synchrotron microXANES probe. Geology1998; 26: 139–142.
51.
DyarMDDelaneyJSSuttonSR. Fe XANES spectra of iron-rich micas. Eur J Mineral2001; 13: 1079–1098.
52.
DyarMDLoweEWGuidottiCV, et al.Fe3 + and Fe2 + partitioning among silicates in metapelites: a synchrotron micro-XANES study. Am Mineral2002; 87: 514–522.
53.
WilkeMFargesFPetitP-E, et al.Oxidation state and coordination of Fe in minerals: an Fe K-XANES spectroscopic study. Am Mineral2001; 86: 714–730.
54.
BeardenJABurrAF. Reevaluation of X-ray atomic energy levels. Rev Mod Phys1967; 39: 125–142.
55.
CottrellEKelleyKALanzirottiA, et al.High-precision determination of iron oxidation state in silicate glasses using XANES. Chem Geol2009; 268: 167–179.
56.
Álvarez-MarimonECastillo-MichelHReyes-HerreraJ, et al.Synchrotron X-ray fluorescence and FTIR signatures for amyloid fibrillary and nonfibrillary plaques. ACS Chem Neurosci2021; 12: 1961–1971.
57.
SpenceHMcNeilCJWaiterGD. Cognition and brain iron deposition in whole grey matter regions and hippocampal subfields. Eur J Neurosci2022; 56: 6039–6054.
58.
CarlesimoGAPirasFOrfeiMD, et al.Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer’s disease. Alzheimers Dement (Amst)2015; 1: 24–32.
59.
HymanBTPhelpsCHBeachTG, et al.National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement2012; 8: 1–13.
60.
DingS-L. Comparative anatomy of the prosubiculum, subiculum, presubiculum, postsubiculum, and parasubiculum in human, monkey, and rodent. J Comp Neurol2013; 521: 4145–4162.
61.
SchindelinJArganda-CarrerasIFriseE, et al.Fiji: an open-source platform for biological-image analysis. Nat Methods2012; 9: 676–682.
62.
InsaustiRAmaralDG. Hippocampal formation. In: PaxinosGMaiJK (eds) The human nervous system (second edition). San Diego: Academic Press, 2004, pp.871–914.
63.
MorrisCMCandyJMOakleyAE, et al.Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel)2008; 144: 235–257.
64.
Gała¸zka-FriedmanJBaumingerERFriedmanA, et al.Iron in parkinsonian and control substantia nigra—A mössbauer spectroscopy study. Mov Disord1996; 11: 8–16.
SchwertmannUCornellRM. FerrihydriteIron oxides in the laboratory: preparation and characterization. Weinheim: John Wiley & Sons, Ltd, 2000, pp.103–112.
67.
OspinaRFerrariSLP. A general class of zero-or-one inflated beta regression models. Comput Stat Data Anal2012; 56: 1609–1623.
68.
SayreLMPerryGHarrisPLR, et al.In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer’s disease. J Neurochem2000; 74: 270–279.
69.
FinneganMEVisanjiNPRomero-CanelonI, et al.Synchrotron XRF imaging of Alzheimer’s disease basal ganglia reveals linear dependence of high-field magnetic resonance microscopy on tissue iron concentration. J Neurosci Methods2019; 319: 28–39.
70.
HackettMJHollingsACaineS, et al.Elemental characterisation of the pyramidal neuron layer within the rat and mouse hippocampus†. Metallomics2019; 11: 151–165.
71.
JamesSAChurchesQIde JongeMD, et al.Iron, copper, and zinc concentration in Aβ plaques in the APP/PS1 mouse model of Alzheimer’s disease correlates with metal levels in the surrounding neuropil. ACS Chem Neurosci2017; 8: 629–637.
72.
LeskovjanACLanzirottiAMillerLM. Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer’s disease. NeuroImage2009; 47: 1215–1220.
73.
Moreno-JiménezEPFlor-GarcíaMTerreros-RoncalJ, et al.Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease. Nat Med2019; 25: 554–560.
74.
HackettMJBritzCJPatersonPG, et al.In situ biospectroscopic investigation of rapid ischemic and postmortem induced biochemical alterations in the rat brain. ACS Chem Neurosci2015; 6: 226–238.
75.
XiaXKongBLiuJ, et al.Influence of different thawing methods on physicochemical changes and protein oxidation of porcine longissimus muscle. LWT - Food Sci Technol2012; 46: 280–286.
76.
HollingsALLamVTakechiR, et al.Revealing differences in the chemical form of zinc in brain tissue using K-edge X-ray absorption near-edge structure spectroscopy. Metallomics2020; 12: 2134–2144.
77.
SzaboSTHarryGJHaydenKM, et al.Comparison of metal levels between postmortem brain and ventricular fluid in Alzheimer’s disease and nondemented elderly controls. Toxicol Sci2016; 150: 292–300.
78.
RathnasamyGLingE-AKaurC. Consequences of iron accumulation in microglia and its implications in neuropathological conditions. CNS Neurol Disord Drug Targets2013; 12: 785–798.
79.
HuangXAtwoodCSHartshornMA, et al.The Aβ peptide of Alzheimer’s disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry1999; 38: 7609–7616.
80.
PolidoriMCPraticòDSungS. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer’s disease. J Alzheimers Dis2004; 6: 171–175.
81.
StockwellBRFriedmann AngeliJPBayirH, et al.Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell2017; 171: 273–285.
82.
WuYTorabiS-FLakeRJ, et al.Simultaneous Fe2+/Fe3 + imaging shows Fe3 + over Fe2 + enrichment in Alzheimer’s disease mouse brain. Sci Adv2023; 9: eade7622.
83.
HambrightWSFonsecaRSChenL, et al.Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration. Redox Biol2017; 12: 8–17.
84.
MandalPKSaharanSTripathiM, et al.Brain glutathione levels – a novel biomarker for mild cognitive impairment and Alzheimer’s disease. Biol Psychiatry2015; 78: 702–710.
85.
Plascencia-VillaGPonceACollingwoodJF, et al.High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer’s disease. Sci Rep2016; 6: 24873.
86.
SchragMCroftonAZabelM, et al.Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer’s disease. J Alzheimers Dis2011; 24: 137–149.
87.
BrenowitzWDNelsonPTBesserLM, et al.Cerebral amyloid angiopathy and its co-occurrence with Alzheimer’s disease and other cerebrovascular neuropathologic changes. Neurobiol Aging2015; 36: 2702–2708.
88.
EverettJLermyteFBrooksJ, et al.Biogenic metallic elements in the human brain?Sci Adv2021; 7: eabf6707.
89.
GenoudSJonesMWMTristBG, et al.Simultaneous structural and elemental nano-imaging of human brain tissue. Chem Sci2020; 11: 8919–8927.
90.
CollingwoodJFMikhaylovaADavidsonMR, et al.High-resolution x-ray absorption spectroscopy studies of metal compounds in neurodegenerative brain tissue. J Phys Conf Ser2005; 17: 54.
91.
HackettMJEllisonGHollingsA, et al.A spectroscopic picture paints 1000 words” mapping iron speciation in brain tissue with “full spectrum per pixel” X-ray absorption near-edge structure spectroscopy. Clin Spectrosc2021; 3: 100017.
